Syndetics omslagsbild
Bild från Syndetics

Merck & Company, Inc. : the recall of Vioxx (B) / Andrew M. Gust, Grant D. Bartucci, James S. O'Rourke.

Av: Medverkande: Materialtyp: TextSerie: Utgivningsuppgift: London : SAGE Publications Ltd, 2017Beskrivning: 1 online resourceInnehållstyp:
  • text
Medietyp:
  • computer
Bärartyp:
  • online resource
ISBN:
  • 9781526406392 (ebook) :
Annan titel:
  • Merck and Company, Inc
Ämnen: DDK-klassifikation:
  • 338.4761699406
Onlineresurser: Influenced by the preliminary results of an internal clinical trial, Raymond Gilmartin, CEO of Merck, announced that the company was pulling its blockbuster arthritis drug Vioxx from the worldwide market on September 30, 2004. Merck & Company, Inc., once the worlds largest pharmaceutical company, saw its stock price plummet 27% after the recall announcement. Facing recent sales declines, a barrage of lawsuits, and two separate government investigations, Merck is losing its once-stellar reputation in the pharmaceutical industry.
Inga fysiska exemplar för denna post

Originally published: Gust, A. M., Bartucci, G. D., & ORourke, J. S. (2005). Merck & Company, Inc.: The recall of Vioxx (B). 05-01 (B). Notre Dame, IN: The Eugene D. Fanning Center for Business Communication, Mendoza College of Business, University of Notre Dame.

Influenced by the preliminary results of an internal clinical trial, Raymond Gilmartin, CEO of Merck, announced that the company was pulling its blockbuster arthritis drug Vioxx from the worldwide market on September 30, 2004. Merck & Company, Inc., once the worlds largest pharmaceutical company, saw its stock price plummet 27% after the recall announcement. Facing recent sales declines, a barrage of lawsuits, and two separate government investigations, Merck is losing its once-stellar reputation in the pharmaceutical industry.

Description based on XML content.

Licensed e-book